Chinanews.com, Nov. 21. The Shanghai Municipal People's Government website reported on the 21st that the General Office of the Shanghai Municipal People's Government recently issued "Several Policies and Measures for Shanghai to Accelerate the Building of a Global Biomedical R&D Economy and Industrialization Highland."
It is proposed that by 2025, Shanghai's global biomedical R&D economy and industrialization highland development pattern will initially take shape, the overall scale of the R&D economy will reach more than 100 billion yuan, cultivate or introduce more than 100 innovative drugs and medical device blockbuster products, and cultivate 50 enterprises The above-mentioned innovative headquarters with complex functions such as biomedical research and development, sales, and settlement have cultivated more than 20 high-level biomedical incubators and accelerators, promoted more than 1,000 biomedical patents to be listed and traded in Shanghai, and added more than 5 biomedical markets. A level engineering research center, providing innovative services such as engineering verification and transformation for more than 100 early high-quality achievements of universities and research institutes.
By 2030, Shanghai's status as a global highland of biopharmaceutical R&D economy and industrialization will be further highlighted, and the overall scale of R&D economy will be further enhanced. The influential biomedical innovation headquarters and innovation platform, and the R&D economy have become an important supporting force for the development of the city's biomedical industry.
(China New Finance and Economics)